Recombinant Human Anti-C17H32O2 Soluble TCR (Bgp) (C-Cys) (CAT#: VS-0622-YF4190)
Human TCR (Bgp) recognizes C17H32O2 peptide (methyl palmitoleate) in the context of CD1a. Soluble TCR is expressed with C-terminal Cys strategy (TRAV-TRAC partial-Cys, TRBV-TRBC partial-Cys). Depending the C-terminal Cys, two chains form heterodimer. Please note that the activity is not guaranteed.
Specific Inquiry
Specifications
- Host Species
- Human
- Target
- C17H32O2
- Epitope
- methyl palmitoleate
- MHC
- CD1a
- Clone
- Bgp
- Type
- Soluble TCR (C-Cys)
- Related Disease
- Autoimmune disease
- TCR Expression Strategy
- C-Cys strategy: the alpha and beta chain (without transmembrane and cytosolic region) can form heterodimer based on C-terminal Cys. The soluble TCR contains variable regions and partial constant regions.
Target
- Alternative Names
- C17H32O2; methyl palmitoleate
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Clone Bgp"
Customer Reviews and Q&As
There are currently no Customer reviews or questions for VS-0622-YF4190. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: WB, FC, IP, ELISA, Neut, FuncS, IF
Application: FC, IP, ELISA, Neut, FuncS, IF, ICC
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: FC, IP, ELISA, Neut, FuncS, IF, WB
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: FC, IP, ELISA, Neut, FuncS, IF, IHC
Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
Application: ELISA, WB, BLI, SPR
Application: Neut, ELISA, WB, SPR, IF, EM
-2.png)
Application: ELISA
Application: WB, FC, IF, Inhib, ELISA, IHC
Application: ELISA, Inhib, FC, Neut
Application: Neut, FuncS, IHC, ELISA, FC, Inhib
For Research Use Only. Not For Clinical Use.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
